The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Onset of neutropenia as an indicator of treatment response in the phase 3 RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo in patients with metastatic colorectal cancer.
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon
 
Alfredo Falcone
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi; Sanofi; SERVIER
Speakers' Bureau - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Bayer; Merck Serono; Roche; Sanofi; Taiho Pharmaceutical
 
Rocio Garcia-Carbonero
Honoraria - Amgen (I); Boehringer Ingelheim (I); Lilly (I); Merck (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - AstraZeneca (I); Boehringer Ingelheim (I); Bristol-Myers Squibb (I); Lilly (I); Merck Sharp & Dohme (I); Novartis (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Novartis; Pfizer; Pfizer (I); Roche; Roche (I); Sanofi
 
Guillem Argiles
Travel, Accommodations, Expenses - Bayer
 
Alberto F. Sobrero
Honoraria - Bayer; Celgene; Merck; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck; Pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; Sanofi
 
Marc Peeters
No Relationships to Disclose
 
Lukas Makris
Employment - Stathmi
Consulting or Advisory Role - Multiple pharmaceutical/biotech companies
 
Fabio M. Benedetti
Employment - Taiho Pharmaceutical
 
Alberto Zaniboni
No Relationships to Disclose
 
Yasuhiro Shimada
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Lilly; Merck Serono; Taiho Pharmaceutical
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb Japan (Inst)
 
Yoshito Komatsu
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Merck Serono; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Merck; Novartis; Pfizer; Yakult Pharmaceutical
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Ben Tran
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Genentech (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Kenichiro Yoshida
Employment - Taiho Pharmaceutical
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Robert J. Mayer
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - CASI Pharmaceuticals